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A B S T R A C T
Since the novel coronavirus disease (COVID-19) emerged in December 2019 in China, it has rapidly spread
around the world, leading to one of the most significant pandemic events of recent history. Deriving
reliable estimates of the COVID-19 epidemic growth rate is quite important to guide the timing and
intensity of intervention strategies. Indeed, many studies have quantified the epidemic growth rate using
time-series of reported cases during the early phase of the outbreak to estimate the basic reproduction
number, R0. Using daily time series of COVID-19 incidence, we illustrate how epidemic curves of reported
cases may not always reflect the true epidemic growth rate due to changes in testing rates, which could
be influenced by limited diagnostic testing capacity during the early epidemic phase.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
Since the novel coronavirus disease (COVID-19) emerged in
December 2019 in China, it rapidly spread globally, and soon after a
pandemic was declared by the World Health Organization on 11th
March 2020 (WHO, 2019, 2020). During the initial growth phase of
epidemics unfolding in entirely susceptible populations and in the
absence of interventions or behavior changes, the rate of change in
the number of new cases is proportional to the number of currently
infectious individuals. As a result, the trajectory of the epidemic
grows exponentially so long as the fraction of the total cases in the
population being detected does not change over time as a result of
temporal changes in testing rates or testing capacity. In this setting,
the trajectory of the epidemic reflects the growth profile of the
epidemic despite the presence of delays in test results. However,
changes in testing rates could artificially distort the true growth
rate, which could result when the testing capacity is ramped up
during the early epidemic's growth phase. For instance, when the
number of new cases per day surpasses testing capacity, the
maximum number of positive test results per day will appear to be
constant, leading to a cumulative incidence curve that artificially
grows linearly. This issue has important implications since the
scope and intensity of public health interventions are largely
guided by metrics that rely on the growth rate of the epidemic,
such as the reproduction number that quantifies the average
number of secondary cases per case. Hence, it is key to assess up to
what extent the time-series of reported cases reflects the true
trajectory of the epidemic. For illustration, we analyzed daily series
of COVID-19 reported laboratory confirmed cases (CFS and SEJHU,
2020) using a linear growth model as well as a non-linear growth
model describing exponential growth. To explore the extended
phase of the epidemic, we employed regression by kernel-window
analysis with a 2-week window.
Our findings reveal an exponential growth phase for the COVID-
19 epidemic in Italy during the entire study period (Fig.1(A)), while
the epidemic in Japan shows linear growth during the first few
weeks. At face value, this pattern would suggest that Japan was
facing a constant infection risk in spite of a growing epidemic
(Fig.1(B)). Linear growth is apparent until 5th March 2020 in Japan,
a trend that suggests that the number of cases exceeded testing
capacity during that period. Indeed, a drastic increase in testing
rate was observed on 4th March 2020 (Fig. 1(C)), which in turn
changes the cumulative positivity rate drastically (Fig. 1(D)) (MOH,
2020). Furthermore, the growth trends in the numbers of both
hospitalized and severe cases (requiring intubation or admission to
ICU), which may be less biased from limited testing capacity, show
signs of exponential growth (Fig. 1(E) and (F)) (MOH, 2020).
Alternative explanations for the early linear growth phase other
than saturated testing capacity could be considered. First, it could
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be the result of preferential testing for highly suspicious samples
leading to a bias in the positive rate among samples. Another
possibility that could be invoked is the effect of interventions, e.g.,
containment, on epidemic growth. Finally, transmission driven by
sporadic outbreaks/clusters might lead to linear growth.
Furthermore, we also found that the trajectory of the epidemic
in California, United States, started with a discontinuous increase
from zero counts on 11th March, 2020, following an exponential
growth (Fig. 1(G)). This abrupt increase is probably the result of
testing delays, reporting delays or difficulties in identifying COVID-
Fig. 1. Classifying the epidemic curve of novel coronavirus disease (COVID-19) into exponential or linear growth phases for different geographic areas and the time-series of
the daily number of tests and the corresponding COVID-19 positivity rate in Japan. Time series data of the reported COVID-19 cases in Italy (A), Japan (B), California, US (G),
hospitalized cases in Japan (E), severe cases in Japan (F). Shaded and white areas separate periods when the observed cumulative incidence curve grows exponentially or
linearly, respectively. To classify the type of growth profile, linear regression and non-linear regression (exponential function) were utilized while the best model fit was
selected using the Akaike Information Criteria (AIC). Time series data of cumulative number of PCR tests in Japan (C) and the cumulative COVID-19 positivity rate among tested
samples (D). Dashed lines in (B), (C) and (D) denote the boundary changes the number of PCR test, between 3rd March and 4th March 2020.
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19 cases during the early phase of the outbreak, a pattern that is
also misleading to the public.
Our results indicate that changes in testing rates, which could
result from limited diagnostic testing capacity, could mask the
epidemic's growth rate, which has public health implications.
Specifically, the derivation of the basic reproduction number
during the early phase of outbreak and the effective reproduction
number during the course of the epidemic are key quantities that
often rely on time-series of reported cases. Hence, biased epidemic
trends can lead to incorrect inferences of metrics characterizing
the transmission potential. Ideally, modelers are interested in case
series by date of symptoms onset to mitigate this bias, but the date
of symptoms onset becomes largely unavailable for epidemics of
rapid dissemination such as COVID-19. Data on the testing strategy
including testing rates as well as estimates of the reporting
probability and ascertainment bias could help derive reliable
inferences of epidemiological and transmission parameters (Ejima
and Nishiura, 2018; Shim et al., 2020; Mizumoto and Chowell,
2020). Trends in numbers of hospitalized/severe cases may also
capture the epidemic growth profile. However, linear growth was
observed after a brief period of exponential growth, likely
reflecting other mechanisms involved (highly variable times from
symptoms onset to admission, heterogeneous severity levels in the
exposed population) or other biases than testing capacity, e.g.,
highly specific testing among hospitalized individuals, limited
hospital bed capacity. Further analysis is required to use the data.
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